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Tomi Lintonen1,2*, Anne Konu2, Sanna Rönkä1,3 and Elina Kotovirta4Abstract
Background: Historically substance misuse has been relatively common in western countries, but comparatively
few Finns report drug use. The Drugs 2020 study aimed at foreseeing changes in the drug situation in Finland by
the year 2020.
Methods: The Delphi method was used, utilizing drug experts of the EU national network in Finland.
Results: Marked growth was foreseen in drug use, especially in synthetic designer drugs and misuse of medicinal
drugs. Significant increase was also expected in growing cannabis at home. However, the control of drug market
was expected to shift more into the hands of organized crime. No consensus was reached on how drug prices will
develop in the time period. Drug use is likely to remain punishable although the use and possession of cannabis
may be treated less severely. It seems likely that health and social services resources will be directed towards
medicinal treatment.
Conclusions: Foresight can be utilized in preparing for the future; desirable developments can be fostered, and
measures can be taken to curb probable but undesirable lines of development. Based on the results of this study,
the experts’ view is that it is highly likely that the Finnish society will have to prepare for an increase in the demand
for drug-related care, both in terms of content of the care and financing the services. Also, the forecasted increase
in the role of legal prescription medicine used as intoxicants will call for efforts not only in changing prescription
practices but in border and police control measures, as well. Parallel developments have been foreseen in the UK
and Sweden, and it is likely that similar trends will actualize also in other western countries.
Keywords: Drug policy, Foresight, Expert panelBackground
After a steady increase in the prevalence since the
1990s, lifetime prevalence of cannabis use in Finland is
now 18.3% which is close to European average [1]. How-
ever, among 15-16-year-olds lifetime prevalence of can-
nabis use has been stable in 2000s, being now 11%.
Lifetime prevalence of use of other illicit drugs in
Finland is rather low: lifetime amphetamine use was
2.3%, and lifetime cocaine use 1.7% [1]. However, the
prevalence of all drug use is notably higher among 25 to
34 year-olds [2]. Conspicuous to Finland, illicit bupre-
norphine is the drug of choice among opioid users [3].
Also other prescription opioids are widely abused,
whereas heroin is almost non-existent in the Finnish
drug market. Buprenorphine was reported as the main* Correspondence: tomi.lintonen@alkoholitutkimussaatio.fi
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unless otherwise stated.problem substance by 32% of the clients entering drug
treatment in 2012, whereas only 1% reported heroin [4].
As in many other European countries, prevailing drug
trends are increasing domestic cannabis cultivation as
well as illicit import and use of so called designer drugs
[1, 3]. The number of seizures of cannabis plants has in-
creased tenfold since 2000: there were 3187 seizures in
2011 [1].
The Finnish drug policy has been characterized as a
dual-track policy: both criminal control and health and
social services have been advanced at the same time [5].
Finland has promoted harm reduction policies – e.g.
opioid maintenance treatment and needle exchange –
when simultaneously tightening criminal control mea-
sures and sanctions. The prevalence of HIV among
IDUs has been low (<2%). Finland is not located on any
major drug trafficking route, but drugs are smuggled
into the country via all neighboring countries and by
air and post [3].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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able to have some kind of outlook of the future. One of
the leading tools in future science is the Delphi method:
"Delphi may be characterized as a method for structur-
ing a group communication process so that the process
is effective in allowing a group of individuals, as a whole,
to deal with a complex problem" [6]. Originating from
the cold war era, the Delphi method was developed for
defense technology forecasting [7]. Although Delphi and
other expert panel methods for planning for the future
are widely utilized in health and social sciences [8, 9],
e.g. in alcohol policy development [10], their use within
the field of drug abuse has been next to non-existent.
Literature searches on psychoactive drug misuse fore-
sight studies yielded only very few publications. Two of
these publications were written by a single expert based
on his insight [11, 12]. More recently, McBride et al.
used Delphi to summarize experts’ views on reducing
misuse of over-the-counter drugs [13]. The most notable
drug policy foresight project has been the Drugs Futures
2025, a Technology Foresight Programme in the United
Kingdom [14]. An editorial written by David Nutt [15]
summarizes the main message as a future of growth in
drug use: in addition to most of the current drugs of
abuse still being around, new drugs with abuse potential
will emerge by year 2025. A list of probable future develop-
ments in and around drug issues was presented together
with possible options and their likely consequences for
politicians to choose from [16]. Detailed predictions were
made e.g. under the headings "Future medicines for mental
health", "Future treatment for addiction", "The future of so-
called 'recreational' drugs", "Future cognition enhancers",
"Management of treatments for mental health", "Manage-
ment of cognition enhancers for the healthy" and "Drug
testing". The program has been criticized for not exploring
the social and cultural contexts of drug use nor the drug
users’ views, and presenting an unnecessarily gloomy future
using “war against drugs” rhetoric [17]. A smaller scale
foresight project was conducted in Sweden in 2010, bring-
ing together the knowledge of around twenty experts [18].
The results were reported in one chapter in a book on the
drug situation and included predictions such as general in-
crease in use and harm resulting from use.
The Drugs 2020 study aimed at forecasting changes in
the drug situation in Finland by the year 2020. The
Delphi method was used with a drug expert network ori-
ginally formed for European Union monitoring pur-
poses. In addition to forecasting the probable future, the
experts were requested to share their views on the desir-
ability aspect of the predicted future. In contrast with
survey studies, the experts also shared their argumenta-
tion behind the predictions. The discussion themes var-
ied from drug use patterns to drug markets and from
drug control to health and social care provision.Methods
Utilizing knowledge and skills of experts, the Delphi
interaction process aims at producing a shared view on
the issue at hand [19]. This shared view is likely to con-
tain features on which most experts agree upon and ele-
ments where expert views differ. The "truth content"
[20] is thought to increase as the number of participants
increases; thus, small panels consisting of only a few ex-
perts are generally not favored. From a Leibnizian view,
two essential qualities determine the ability of the com-
munication process, such as the Delphi, to produce rele-
vant information: the quality of the information held by
the participants and the number of participants [20]. On
the other hand, a Lockean stance on the truth content
states that the method should be judged by its power to
reduce complex issues to simpler statements and agree-
ment on issues between different individuals [20]. Develop-
ments in the information technology have brought forward
new ways of expert communication within the Delphi
framework [20]. The traditional "wave" structure of the Del-
phi panel has recently somewhat dissolved and given way
to continuous discussion that utilizes interactive web-based
platforms [21]. This methodological extension is widely re-
ferred to as the "Real Time Delphi" [22]. In the current
study, the project ideology came close to a Policy Delphi
[23] as it did not aim at generating consensus but freely ac-
cepted discordance as a collective expert view. Drugs 2020
utilized a 'Real Time Delphi' -type [22] internet service
called eDelfoi (www.edelphi.fi).
The European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) coordinates a network of national
focal points (NFPs) set up in the 27 EU Member States,
Norway, the European Commission and in the candidate
countries. The network is called Reitox, the European
Information Network on Drugs and Drug Addiction. In
Finland, the focal point was established in 1995 and the
members of the national network of experts were used
as informants in this Delphi study. The number of ex-
perts was 43 at the start of the study process, and these
same experts comprise the national network in the
European Monitoring Centre for Drugs and Drug Addic-
tion. They have been assigned to this network to provide
the European Union with comprehensive information on
the drug situation in Finland. The experts came mainly
from the public sector, but third sector actors were also
involved from institutions like The National Institute
for Health and Welfare, Statistics Finland, University of
Helsinki, Ministry of Justice, Ministry of Social Affairs
and Health, Ministry of Education and Culture, Customs
service, National Bureau of Investigation (Police), City of
Helsinki, Nordic Centre for Welfare and Social Issues,
Finnish Medicines Agency, Finnish Society for Social
and Health, the Helsinki Deaconess Institute and the
A-Clinic Foundation. These institutions and organizations
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planning in Finland. The experts are professionals in e.g.
social sciences, medicine, chemistry, police, civil service,
and law, and are in a position to estimate the development
of Finnish drug situation.
The invitations to take part in the discussions were
sent to the Finnish Reitox experts email list. It was em-
phasized that taking part was voluntary and absolutely
anonymous. After registration to the eDelfoi website
with an email address the participant could take part in
the discussions. Only the eDelfoi site technical manager
was able to access the email database. It was also em-
phasized that a temporary email address could be set
up just for this purpose, in case the experts did not
want to use their existing addresses. Thus, not even
the researchers could know who answered what, let
alone make it public. This was done in order to en-
courage honest personal views instead of so called offi-
cial institutional views. The number of experts taking
part in each of the three Delphi discussion rounds was
19, 18 and nine.
The three Delphi rounds were conducted during
2009–2011. The time for each discussion was limited to
two weeks per round. The number of themes was lim-
ited to fifteen per round to encourage participation.
Themes for the first Delphi round were developed
within the research team. The second and third rounds
included questions and topics formulated on ideas pre-
sented by the experts during the preceding rounds. Cer-
tain statements were re-issued on successive rounds,
both in same wording and also in slightly developed
form. This was done to clarify the issues in terms of
evaluations of probability and justifications.
The majority of topics were dealt with by issuing a state-
ment (e.g. 'Drug prices will decrease due to the supply ex-
ceeding demand.'), and requesting the respondent to
choose between six alternatives: 'Highly likely', 'Likely',
'Not likely nor unlikely', 'Unlikely', 'Highly unlikely' and
'Cannot say'. In addition, probable prevalence of certain
phenomena was inquired with questions like 'How com-
mon is the use of cocaine likely to be in the year 2020?'.
The options ranged from 'Very rare (less than half of the
current situation)' to 'At least three times as common as
currently'. In conjunction with most topics, the desirability
of the development was also inquired on a five-point scale
ranging from 'Very desirable' to 'Not at all desirable',
including the option 'Cannot say'. In four statements
the desirability was presupposed as obvious, e.g. medi-
cinal drugs causing more deaths, and thus the question
of desirability was not asked. These cases are marked
“na” in Table 1. In addition to inquiring about the like-
lihood and desirability of certain developments, the
experts were also advised to justify their choices in
their own words.In contrast with survey questionnaires, the web-based
response platform was open for the experts to view
others’ responses and adjust their own during the two
week window for each discussion round. The Delphi
method aims at promoting deliberation and making in-
formed predictions on the future, and thus encourages
information sharing. The experts were able to view the
preliminary results, both quantitative and qualitative.
They were also able to amend or change their own views
in case other justifications made sense to them.
Results
Drug use and use patterns
All in all, the use of drugs was predicted to be more
widespread in Finland by the year 2020 compared to
current situation (Table 1). Use of psychotropic medicine
as intoxicants, as well as use of new synthetic drugs was
seen as areas of particular growth. In their open-ended
justifications the respondents explicated that most drug
users reason that drugs manufactured by the pharma-
ceutical industry are both safer and easier to access. In
the case of new synthetic drugs, both the increased
access to process chemicals through internet and the in-
structions available online were seen as particular driv-
ing forces behind the predicted increase. Both of these
phenomena were considered undesirable, although a
number of respondents noted that medicinal drugs may
cause less harm than illegal substances. However, other
respondents brought forward that potential disappear-
ance of the differentiation between medicinal drugs and
drugs of abuse may encourage the use of medicine to
non-medical purposes. The experts unanimously dis-
missed the idea that drug use would become less com-
mon due to population ageing - this was considered to
be wishful thinking.
On the first Delphi round, the experts were asked how
common they thought the use of cocaine would be in
2020 compared to the current prevalence (=100%). Half
of the respondents predicted the use of cocaine to be
somewhat more common than now. When the same
question was presented to them on the second round,
two thirds thought the use will have increased. Half of
the experts predicted slight increase (less than 50% in-
crease) and no one foresaw greater than two-fold in-
crease. According to the respondents’ justifications, the
potential for increase was seen to be rather small due to
the strong culture of amphetamine use in Finland. How-
ever, the respondents admitted that cocaine is much
more popular in most other European countries, and
this causes obvious pressure for increase also in Finland.
It was also noted that the growth seen in designer drugs
may well override the potential for cocaine use increase.
On both the first and the second Delphi round the ex-
perts were asked to estimate "How common growing
Table 1 The probability and desirability of changes until the year 2020
Probability Desirability
Drug use and use patterns
The use of drugs is less common in 2020 than it is now. – na
The use of drugs has diminished due to population ageing. – ++
The use of psychotropic medicine as intoxicants is more common than the use of illegal substances. + –
The use of new synthetic drugs is much more common in 2020 than it is now. + –
Use cultures and modes of use are more distinct and separated in 2020 and multi-drug use is less common. – |
Drug markets
Drug prices decrease due to supply exceeding demand. | –
Drugs and psychotropic medicine parly replaces alcohol drinking. – – –
In 2020, drug import and wholesale is controlled by organized crime more than it is now. + na
Drug control
Drug use and possession for own use is no longer illegal in 2020. – |
Use and possession of cannabis is no longer illegal in 2020. | |
In practice, use and possesion of cannabis is no longer punished in 2020. | |
Home growing cannabis for own use is no longer punishable in 2020. | |
The amount of designer drugs diminishes considerably due to new legislation speeding up their classification as illegal. – ++
The Police no longer needs a court order to access telecommunications of suspected drug dealers. | |
A prison sentence due to drugs ordered by a court can be transformed into doing time in an intoxicant care institution. + +
Health, care and the care system
A serious HIV epidemic has been experienced among injecting drug users by the year 2020. – na
The use of psychotropic medicine as intoxicants causes more deaths in 2020 than now. + na
Harm reduction has led to implementing use rooms for injecting drug users. – – |
A substitution therapy has been implemented widely for amphetamine addiction. | +
Resources in drug therapy have been focused in medicinal therapy. | –
Injecting drug users can be forced involuntarily to therapy in 2020. – –
Under-aged drug users can be forced involuntarily to therapy in 2020. | |
Drug therapy is offered almost entirely by the third sector. | –
Drug therapy is offered almost entirely by primary health care services in municipalities. ++ ++
There are notably more combined mental health and drug addiction care units in municipalities in 2020. + +
Access to mental health care, including medication, has improved considerably in 2020, and this has diminished drug use. – ++
Attitudes toward drugs
Drug use approval has widened in sports, business and cultural circles. + – –
The society is markedly more negative towards drugs and the consequences are more severe than now. | |
Probability: "–" no-one agreed, "-" more than two thirds disagreed, " + " more than 2/3 agreed, "++" no-one disagreed.
Desirability: "–" no-one held desirable, "-" more than two thirds held undesirable, " + " more than 2/3 held desirable, "++" no-one held undesirable.
"|" no agreement on whether the issue is probable (desirable) or not probable (undesirable).
"na" not applicable, was not asked.
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The majority expected increase; the first time the mode
was "50% more than now" whereas the second time the
mode was "100% more than now". Only few saw the
phenomenon as something which may be popular now
but will go away soon. The respondents’ view was that
home growing is seen to have so many benefits for the
users compared with buying cannabis from criminal
market that it would be very difficult to counteract thiswith increased control. The experts also noted that the
risk of being caught is not high and not likely to grow.
Drug market
The control of drug market in Finland was expected to
shift more into the hands of organized crime (Table 1).
The respondents expressed that this is partly due to the
anticipated growth of the market which will attract lar-
ger scale players to the scene. Furthermore, they pointed
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worked with the international drug trade. The minority
of the respondents, who thought this kind of develop-
ment not probable, justified their thinking by hope that
drug control will be directed more towards criminal or-
ganizations as opposed to individual users.
No consensus was reached on how drug prices will
develop in the time period. Those expecting a price de-
crease thought that home-grown cannabis and cheap
synthetic drugs are likely to increase the supply of drugs.
Those with the opposing view saw that organized crime
will act like a monopoly and keep prices steady or even
increasing.
Drug control
The experts were markedly divided in their views on the
future of drug control issues in Finland (Table 1). More
than half of the drug control statements were considered
neither probable nor improbable. Furthermore, the ex-
perts did not agree on whether the suggested develop-
ments were desirable or undesirable, except on two
topics. Speeding up the classification of new synthetic
substances as illegal drugs was strongly desired to help
curb the increase in usage; however, the majority of the
experts did not think this legislative action could do the
job because of the infinite potential to alter these sub-
stances. Most of the experts were in favor of making it
possible to transform a drug-related prison sentence into
therapy period in an intoxicant care institution - and the
majority thought this is likely to happen by the year
2020.
Health, care and the care system
Among the experts, strong consensus existed on what
the main institution bearing the biggest load in drug
user health care would be: most likely the local munici-
pal primary care services (Table 1). Furthermore, experts
were unanimous that this is a desirable way to go. Of
the alternatives, specialized health care was seen as un-
necessarily expensive. The respondents’ view was that
the number of patients with drug-related health prob-
lems has been on the increase and is likely to further in-
crease, and thus the expertise on drugs in the primary
health services will have to grow. Currently, third sector
bodies such as non-profit organizations and foundations
provide a notable part of these services, but an expan-
sion of their role was considered neither probable nor
desirable. The experts also envisioned that the municipal
care services are likely to develop into integrated mental
health units incorporating drug services.
Regarding intravenous drug users, injection rooms
were considered a very unlikely development in Finland,
as was the idea of forced involuntary therapy. The
experts' views were strongly divided in predicting thefollowing developments: replacement therapy for am-
phetamine users, medicalization of care, and involuntary
therapy for under-age users. On one hand, amphetamine
replacement therapy was seen as a desirable opportunity
but, on the other hand, concentrating on medicinal ther-
apy was thought as an undesirable development: this
view was based on experiences with opioid substitution,
more precisely the so-called substitution therapy de-
pendence. Although not necessarily likely, the possibility
to force therapy on the under-age users would be wel-
comed by the experts.
The majority of experts estimated that the amount of
people in opioid replacement therapy would grow in the
coming years; the estimate of a 50% increase seemed
most likely. It was noted that even if opioid use did not
become more common in Finland, more services would
be needed since not nearly all care demands are met
currently. Furthermore, therapy is long-lasting, and few
actually ever stop using opioids.
Attitudes towards drugs
The experts did not see any strong trend in public atti-
tudes towards drugs in the future (Table 1). However, a
slight shift to more permissive attitudes was envisioned.
The respondents’ main argument was that in most areas
of life competition is getting tougher and, therefore, new
means for success are sought and at least quietly ap-
proved of. The opponents to this view referred to the
development seen in smoking: smokers are increasingly
seen as “pathetic losers”, as one expert phrased it. Re-
garding the desirability of attitude change, the experts
were unanimous in condemning any change towards
wider approval. More widespread approval of drugs was
seen to promote increase in drug use. The experts did
not favor hardening the consequences, especially crim-
inal sentences.
Discussion
The Drugs 2020 study aimed at forecasting changes in
the drug situation in Finland by the year 2020. The
Delphi method was used, and ideology of the study came
close to a Policy Delphi as it did not aim at forced con-
sensus but freely accepted discordance as a collective ex-
pert view. The experts agreed on the view that drug use
is likely to become more common in Finland by 2020.
Marked growth was foreseen especially in synthetic de-
signer drugs and misuse of medicinal drugs. Significant
increase was also expected in growing cannabis at home.
However, the control of drug market was expected to
shift more into the hands of organized crime by 2020.
Regarding criminal sanctions, the use and possession of
cannabis may be treated less severely by 2020 – this be-
ing a highly debated issue in Finland, as well as in most
other western countries.
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experts seemed rather conservative in their predictions,
as were their Swedish colleagues [18]. In fact, the
Swedish experts foresaw future developments, such as
general increase in use as well as marked increase in
intoxicant use of prescription medicine and synthetic
drugs, in much the same way as their Finnish counter-
parts. Drug legalization processes are not likely to ad-
vance in Sweden, although the experts pointed out that
there will be increased pressure towards this develop-
ment from neighboring countries [18] – Finnish ex-
perts predicted exactly the same. Another mutually
shared view was on the likelihood of medicinal care
growing at the expense of psycho-social care: in light
of current economic situation, cutting public spending
is likely to speed up this line of development. All in all,
the future predicted for Sweden [18] seemed strikingly
similar to the one foreseen for Finland by the Finnish
experts.
In the UK, on the other hand, experts were notably
more innovative in their predictions of the future, pos-
sibly partly due to the longer prediction time-frame.
One other likely explanation lies in the differences in
current drug situations: whereas Finland and Sweden
can be considered countries with limited and con-
trolled drug use, the situation in the UK is further ad-
vanced and dynamic. Furthermore, the UK foresight
study seemed to emphasize out-of-the-box thinking,
and encouraged the experts to think in terms of possi-
bilities for innovation alongside threats [14]. Thus, the
experts came out with predictions such as vaccines for
addictions, new legal psychoactive substances for rec-
reational use, and cognition enhancers for use in the
working life [24]. However, following the lines of the
Finnish foresight project, experts in the UK thought it
likely that drug-related deaths will become more com-
mon and drug crime will increase.
Foresight settings, research questions and method-
ologies have often been evaluated as poorly performed
surveys or inadequate prospective policy studies. In
contrast with other methods, the main logic behind a
Delphi expert panel is facilitating structured expert
communication on an issue that evades study when
traditional methods are used. The Delphi method has
been considered useful when means of establishing and
articulating the views of experts is needed [25, 26]. The
methodological considerations in a Delphi study are
different from both survey studies and interview stud-
ies; for example, the method calls for a heterogeneous
set of experts to ensure that conflicting views can be identi-
fied. As a reaction to criticism on one-sided thinking in the
UK futures project [17], for our study we invited experts
representing a wide variety of institutions and professions.
On the first and second discussion rounds, roughly half ofthe eligible experts participated in the process. The third
round failed to inspire the experts to participate, possibly
since the most important questions had already been cov-
ered. We have no way of knowing who the respondents
were, but we can still be sure that, even with the low re-
sponse on round three, the diversity in expertise was
retained at least to some degree as none of the institutions
were represented by a numerous amount of experts.
Although, due to anonymity we cannot explicitly study the
qualities of the respondents versus those who did not par-
ticipate, we did receive voluntary information from some
eligible experts on their non-participation. A common ex-
planation for not taking part was a feeling of inadequacy.
Many felt they were experts in such a narrow field that they
did not feel competent to take part in a discussion on wider
issues; an example would be a chemist analyzing cannabin-
oid content of confiscated specimen. It is unlikely that any
one person could be an expert on all issues and aspects of
the future of drugs, and we judged that the EU national
network of experts was and is the best existing collection of
experts available.
Although this Delphi study on the probable future re-
lated to drugs in Finland was based on an established
network of experts, brought together for European Union
drug situation monitoring purposes, other experts like
many academically oriented researchers were not included
in the process. Clinicians involved in the treatment of drug
users were not included, nor were drug users themselves.
Thus, it must be remembered that the view on a probable
future depicted in this study is likely to be an institutional
view rather than a view of an individual. It is also worth
noting that seeing the future as an extension of current
trends is the easiest mode of thinking [27]. Many of the
predictions made in the current study for Finland, as well
as in the Swedish study [18], can be classified as extrapola-
tions of past trends.
Conclusions
Foresight can be utilized in preparing for the future: de-
sirable developments can be fostered and measures can
be taken to curb probable but undesirable lines of devel-
opment. Based on the results of our study, the experts
view is that it is highly likely that the Finnish society will
have to prepare for an increase in demand for drug-
related health care, both in terms of care content and fi-
nancing the services. As it is likely that the amount of
drug users and demand for health care will increase, the
experts saw that the emphasis in care will have to shift
away from specialized services nearer to the citizens, to
primary care. Also, the likely increase in the role of legal
prescription pharmaceuticals used as intoxicants will call
for efforts not only in changing prescription practices
but in border and police control measures, as well. The
most topical development need relates to a process
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tronic database for prescriptions. This database can be
utilized to detect and limit the sales of drugs with poten-
tial for misuse. Even if the national drug policy is to re-
main the same, i.e. based on both criminal sanctions and
on health and social services [4], the results of our study
call for a more open discussion on policy objectives and
practical measures to control both the use of drugs and
harm caused by them. Parallel developments were fore-
seen in the foresight studies conducted in the UK [14]
and Sweden [18], and it is likely that similar trends will
actualize also in other western countries.
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